| Dr Timur Tafari Graham, MD | |
|
203 Plymouth Ave Ste 702, Fall River, MA 02721-4300 | |
| (508) 679-4239 | |
| (508) 679-3702 |
| Full Name | Dr Timur Tafari Graham |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 203 Plymouth Ave Ste 702, Fall River, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497933683 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 273387 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Anne's Hospital | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prima Care Pc | 2567356017 | 186 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
The researcher of the Faculty of Science of the UMA Adrián Ruiz-Villalba, who is also member of the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) and the Biomedical Research Institute of Malaga (IBIMA), is the first author of an international study that has identified the heart cells in charge of repairing the damage caused to this organ after infarction.
The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.
GVK Biosciences, Asia's leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India.
› Verified 2 days ago
| Entity Name | Prima Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265422596 PECOS PAC ID: 2567356017 Enrollment ID: O20040214000027 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
The researcher of the Faculty of Science of the UMA Adrián Ruiz-Villalba, who is also member of the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) and the Biomedical Research Institute of Malaga (IBIMA), is the first author of an international study that has identified the heart cells in charge of repairing the damage caused to this organ after infarction.
The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.
GVK Biosciences, Asia's leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India.
› Verified 2 days ago
| Entity Name | General Pulmonary Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922646140 PECOS PAC ID: 6406283662 Enrollment ID: O20200227002010 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
The researcher of the Faculty of Science of the UMA Adrián Ruiz-Villalba, who is also member of the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) and the Biomedical Research Institute of Malaga (IBIMA), is the first author of an international study that has identified the heart cells in charge of repairing the damage caused to this organ after infarction.
The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.
GVK Biosciences, Asia's leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timur Tafari Graham, MD 203 Plymouth Ave Ste 702, Fall River, MA 02721-4300 Ph: (508) 679-4239 | Dr Timur Tafari Graham, MD 203 Plymouth Ave Ste 702, Fall River, MA 02721-4300 Ph: (508) 679-4239 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
The researcher of the Faculty of Science of the UMA Adrián Ruiz-Villalba, who is also member of the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) and the Biomedical Research Institute of Malaga (IBIMA), is the first author of an international study that has identified the heart cells in charge of repairing the damage caused to this organ after infarction.
The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.
GVK Biosciences, Asia's leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India.
› Verified 2 days ago
Stephen Zuehlke, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 289 Pleasant St, Suite 301, Fall River, MA 02721 Phone: 508-679-9955 Fax: 508-679-1435 | |
Terence J Mcgovern, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave, Suite 210, Fall River, MA 02720 Phone: 508-973-1780 Fax: 508-973-0359 | |
Raju Singla, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 289 Pleasant St, Fall River, MA 02721 Phone: 508-646-7730 Fax: 508-672-0885 | |
Ronald Bruce Goodspeed, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-679-7013 | |
Linsey Philip, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 277 Pleasant St, Suite 306, Fall River, MA 02721 Phone: 508-675-3232 Fax: 508-675-4942 | |
Dr. Tricia A Carty, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 534 Prospect St, Fall River, MA 02720 Phone: 508-973-7766 Fax: 508-973-7753 | |
Dr. Nick Mucciardi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 President Ave, Suite 210, Fall River, MA 02720 Phone: 508-973-1780 Fax: 508-973-0359 |